ICM
LCTX icon

Ionic Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Ionic Capital Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,117
Closed -$77K – 345
2016
Q4 		$77K Hold
24,117
– – ﹤0.01% 326
2016
Q3 		$82K Buy
+24,117
New +$66.6K ﹤0.01% 345
2016
Q2 		– Sell
-247,002
Closed -$620K – 340
2016
Q1 		$620K Sell
247,002
-141,800
-36% -$316K 0.04% 195
2015
Q4 		$1.29M Buy
+388,802
New +$1.16M 0.09% 175

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return